WHAT'S NEW

"Our latest patient forum & dinner was a success! Read about it if you missed it, share the story if you were there: http://t.co/kedECWf3IA - 1 day ago via Twitter
"Many thanks to everyone who joined us at the Patient Forum and Dinner, “Antiangiogenesis: Answer to Cancer." Here's a synopsis for those who couldn't make it: http://www.angio.org/patient-forum-and-dinner-antiangiogenesis-answer-to-cancer/. And don't forget! You can join Eat To Defeat Cancer and Do it Yourself Health to EAT, MOVE, SLEEP, & SMILE towards better health. - 1 day ago via Facebook
On October 14, the Angiogenesis Foundation hosted a Patient Forum and Dinner, "Antiangiogenesis: Answer to Cancer," at the Westin Boston Waterfront Ho Read More >
"Angiogenesis-based medicine is a new, comprehensive approach to fighting disease. Learn about it here: http://t.co/thMW8Mw90x - 4 days ago via Twitter
"The first clinical trial of an antiangiogenic drug (TNP-470) began in 1992 in cancer patients. Get more facts here! http://t.co/z9RHAoso6H - 5 days ago via Twitter
"Aflibercept injection shown to be superior to bevacizumab and ranibizumab in visual acuity gains for DME patients: http://t.co/FgE7ZDmAgt - 5 days ago via Twitter
The U.S. Food and Drug Administration (FDA) has approved EYLEA® (aflibercept) Injection for the treatment of Macular Edema following Retinal Vein Occ Read More >
"Interesting treatment clues from these cases with mTOR inhibitor everolimus. - 1 week ago via Facebook
"Anti-VEGF Agent Aflibercept FDA Approved for Treating Macular Edema Following Retinal Vein Occlusion (RVO): http://t.co/1lCdr9fWjY - 1 week ago via Twitter
"More treatment options for saving vision! - 1 week ago via Facebook
"#WorldSightDay honors the millions who are visually impaired & reminds us that we can take steps to prevent vision loss. Let's save vision! - 2 weeks ago via Twitter
"World Sight Day honors the millions of people who are visually impaired and reminds us that each of us can take steps to protect our vision from some of the leading causes of vision loss worldwide: age-related macular edema, diabetic macular edema, and retinal vein occlusion. Support our mission to save vision around the globe with the help of anti-VEGF therapy. Learn more and share at The Science of AMD, Science of DME, and the Science of RVO. - 2 weeks ago via Facebook
"October is National Breast Cancer Awareness Month in the U.S. Learn about anti-angiogenic therapy for metastatic breast cancer with our free e-publication, available here: http://www.angio.org/pdf/Angio_MBC_FINAL_Publication.pdf - 2 weeks ago via Facebook
"In total, more than 300 angiogenesis inhibitors have been discovered to date. Learn more: http://t.co/Vtq43SbDgP - 2 weeks ago via Twitter
"In the U.S., there are currently thirteen approved anti-cancer therapies with recognized antiangiogenic properties in oncology. These agents, which interrupt critical cell signaling pathways involved in tumor angiogenesis and growth, comprise of three primary categories: 1) monoclonal antibodies directed against specific proangiogenic growth factors and/or their receptors; and 2) small molecule tyrosine kinase inhibitors (TKIs) of multiple proangiogenic growth factor receptors; 3) inhibitors of mTOR (mammalian target of rapamycin). Learn more: - 2 weeks ago via Facebook
"13 anticancer therapies with recognized antiangiogenic properties are approved in the US. Learn more: http://t.co/oIb5oeGC0w - 2 weeks ago via Twitter
"How can we predict response to therapy in metastatic CRC? Could AngioPredict lead the way? See the lecture here, given by Anette Byrne, Ph.D.: - 2 weeks ago via Facebook
"Check out videos, white papers, brochures and infographics from our many programs--all in one place! - 3 weeks ago via Facebook
"Did you know? Our veins contain 65% of the body's total blood supply at any given moment! - 3 weeks ago via Twitter
"Angiogenesis is your lifeline. Find out why: ow.ly/vMBF7 - 3 weeks ago via Facebook
"Tune in to our webcasts and "Hear from the Experts" about new angiogenesis-based therapies: http://t.co/QQoX8dz3Dm - 3 weeks ago via Twitter
"The “Best of Antiangiogenesis” is a series of presentations from leading medical experts describing research and perspectives on new angiogenesis-based therapies. View our library here: - 4 weeks ago via Facebook
"Angiogenesis pioneer Dr. Judah Folkman’s legacy of bold and creative thinking endures: - 4 weeks ago via Facebook
Bayer HealthCare's Japanese subsidiary, Bayer Yakuhin, Ltd. has received approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) for Read More >
The U.S. Food and Drug Administration, on August 14, 2014 approved bevacizumab solution for intravenous infusion (Avastin®, Genentech, Inc.) for the Read More >
Aflibercept (EYLEA) Injection has been approved by the European Commission for the treatment of visual impairment due to Diabetic Macular Edema (DME). Read More >
The U.S. Food and Drug Administration (FDA) has approved aflibercept (EYLEA®) Injection for the treatment of Diabetic Macular Edema (DME). The recom Read More >
The U.S. Food and Drug Administration (FDA) has accepted a supplemental Biologics License Application (sBLA) from Genentech and granted Priority Revie Read More >
In a new study published online in the Journal of the American Heart Association June 12, 2014, researchers at Columbia Engineering report that they h Read More >
A new oral drug called lenvatinib looks promising as a treatment for a type of thyroid cancer that resists standard radiation, according to a later-st Read More >
Bevacizumab (Avastin) becomes the first biologic medicine to be recommended for treating platinum-resistant recurrent ovarian cancer, the most challen Read More >
Aflibercept (EYLEA®) injection has been recommended for approval by the European Committee for Medicinal Products for Human Use (CHMP) for the treatm Read More >

ANGIO LIFE

Dr. Li shares 22 Cancer Fighting Tips with Dr. Oz

Dr. William Li joins Dr. Oz to share 22 ways to cut your risk of cancer risk by 50 percent. Read More >

Dr. William Li presents at TED

Dr. William Li presents “Can we eat to starve cancer?” at TED 2010 in Long Beach, CA. Read More >

 

IN THE MEDIA

DoctorOZ-1

May 20, 2014: “The Dr. Oz Show” features Dr. William Li who shares 3 all-natural breakthroughs that can reduce your risk of cancer. Read More >

DoctorOZ (1)

February 7, 2014: Dr. William Li appears on “The Dr. Oz Show” to share 22 ways to cut your cancer risk by 50%. Read More >

4744.Reuters-Logo

January 21, 2014: The Angiogenesis Foundation, in collaboration with musician / activist Peter Gabriel, has launched the Do iT Yourself Health Revolution Read More >

yahoo-news-logo

November 7, 2013: The Angiogenesis Foundation receives highest rating from Charity Navigator, a premiere charity evaluator, for good governance, fiscal management, accountability and transparency. Read More >

marketwatch-logo

September 26, 2013: The Angiogenesis Foundation Launches Multimedia Campaigns for Saving Vision at the 13th Euretina Congress Read More >

4744.Reuters-Logo

September 26, 2013: The Angiogenesis Foundation Releases International White Paper on Improving Outcomes in the Treatment and Management of Metastatic Colorectal Cancer at the European Cancer Congress 2013 Read More >

yahoo-news-logo

September 26, 2013: The Angiogenesis Foundation Releases International White Paper on Advancing Treatment of Wet Age-Related Macular Degeneration at the 13th Euretina Congress Read More >

WSJ-Logo2

July 16, 2013: The Angiogenesis Foundation Presents Concept of Antiangiogenic Foods at IFT 2013 Annual Meeting + Food Expo Read More >

usatoday_logo

June 4, 2013: Dr. William Li discusses the impact of drug shortages for cancer patients in USA Today. Read More >

usatoday_logo

June 3, 2013: Dr. William Li discusses recent developments for patients with metastatic thyroid cancer in USA Today. Read More >

WSJ-Logo2

May 31, 2013: The Angiogenesis Foundation releases Advancing Critical Pathways Forward in the Treatment of Colorectal and Kidney Cancer – White Papers at the ASCO Annual Meeting 2013. Read More >

WSJ-Logo2

May 30, 2013: The Angiogenesis Foundation Launches Science of Colorectal Cancer Patient Resource at ASCO Annual Meeting 2013. Read More >

WSJ-Logo2

May 7, 2013: The Angiogenesis Foundation releases white paper, “Critical Pathways Forward for Wet Age-Related Macular Degeneration in Asia Pacific.” Read More >

usatoday_logo

April 21, 2013: Dr. William Li describes how therapeutic angiogenesis could help Boston Marathon bombing survivors heal and recover from injury. Read More >

Doctor Oz

May 29, 2012: Dr. William Li discusses everyday healthy foods in your grocery store that have cancer-fighting properties.
Read More >

HEAR FROM THE EXPERTS

   

The “Best of Antiangiogenesis” is a series of webcasts, generated through Project ENABLE™, featuring presentations from leading medical experts describing research and perspectives on new angiogenesis-based therapies.

To view additional webcasts, click here
 

LEARN ABOUT DISEASE TREATMENTS

PUBLICATIONS

GREEN TEA

Our tea research is part of our Eat to Beat Cancer initiative, which is setting out to find foods and beverages that restore balance to the body's angiogenesis system. By purchasing this tea you are supporting our research and helping to advance the frontiers of cancer prevention.